- Title: Subtitle
- A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
- Creators
- Steven R Lentz - Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA, USAAnand Tandra - Hematology, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN, USARobert Z Gut - Clinical, Medical, and Regulatory Affairs, Novo Nordisk, Inc, Princeton, NJ, USADavid L Cooper - Clinical, Medical, and Regulatory Affairs, Novo Nordisk, Inc, Princeton, NJ, USA
- Resource Type
- Letter/Communication
- Publication Details
- Journal of blood medicine, Vol.5(default), pp.1-3
- DOI
- 10.2147/JBM.S55216
- PMID
- 24470784
- PMCID
- PMC3894958
- NLM abbreviation
- J Blood Med
- ISSN
- 1179-2736
- eISSN
- 1179-2736
- Publisher
- Dove Medical Press
- Language
- English
- Date published
- 2014
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094529302771
Letter/Communication
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
Journal of blood medicine, Vol.5(default), pp.1-3
2014
DOI: 10.2147/JBM.S55216
PMCID: PMC3894958
PMID: 24470784
Abstract
Details
Metrics
36 Record Views